{
    "code": "52027303",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027303",
    "time": "2022-08-05 06:57:01",
    "許可證字號": "衛部藥輸字第027303號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/11\/06",
    "發證日期": "106\/11\/06",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202730302",
    "中文品名": "寧癌平凍晶注射劑",
    "英文品名": "Orimustine",
    "適應症": "1.Binet分類stage B及C之慢性淋巴球白血病(chronic lymphocytic leukemia, CLL)。2.曾接受至少一種化療之和緩性非何杰金氏淋巴瘤，六個月內曾以rituximab治療失敗之單一治療。3.Bendamustine合併Rituximab適用於先前未曾接受治療的CD20陽性、第 III \/ IV 期和緩性非何杰金氏淋巴癌(non-hodgkin lymphoma, NHL)。Bendamustine合併Rituximab適用於先前未曾接受治療且不適合自體幹細胞移植的第 III \/ IV 期被套細胞淋巴癌(mantle cell lymphoma, MCL)。",
    "劑型": "243凍晶注射劑",
    "包裝": "25毫克及100毫克棕色玻璃小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BENDAMUSTINE HYDROCHLORIDE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "0416601100  友華生技醫藥股份有限公司",
    "申請商地址": "台北市復興南路一段３６８號７樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCZ0024000  ONCOMED MANUFACTURING A.S.",
            "製造廠廠址": "KARASEK 2229\/1B, BUDOVA 02, 62100 BRNO-RECKOVICE, CZECH REPUBLIC",
            "製造廠公司地址": "",
            "製造廠國別": "CZECH REPUBLIC",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "0416604300  友華生技醫藥股份有限公司桃園製藥廠",
            "製造廠廠址": "桃園市桃園區大誠路11號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FNL0113000  SYNTHON BV",
            "製造廠廠址": "MICROWEG 22, 6545 CM NIJMEGEN, THE NETHERLANDS",
            "製造廠公司地址": "",
            "製造廠國別": "NETHERLANDS",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002510",
            "成分名稱": "BENDAMUSTINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "25.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1004002510",
            "成分名稱": "BENDAMUSTINE HYDROCHLORIDE",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Orimustine-25mg-108-04-01(廠商自行上傳).PDF",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027303&Seq=002&Type=10"
        },
        {
            "title": "衛部藥輸字第027303號_Orimustine_藥物外觀-107-01-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027303&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部藥輸字第027303號-111-07-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027303&Seq=003&Type=9"
        },
        {
            "title": "衛部藥輸字第027303號_Orimustine_標籤外盒-109-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027303&Seq=002&Type=8"
        },
        {
            "title": "衛部藥輸字第027303號_Orimustine_標籤外盒-107-01-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027303&Seq=001&Type=8"
        }
    ]
}